Globalworld globe
United Kingdom
North America
Europe
  • facebook
  • linkedin
Medical Developments International
  • Home
  • Products
    • Asthma & COPD
    • Penthrox
  • About
    • Distributor Information
    • Careers
    • Associations
  • Investors/Media
    • Financial Reports
    • Board of Directors/Management
    • Corporate Governance
    • Media Centre
    • Diversity Policy
    • Share Trading Policy
  • Healthcare Professionals
  • Contact

News

Major licensing deal for Europe

Jun 28, 2015Cathy WilsonNews

 

29 June 2015

ASX ANNOUNCEMENT

Major licensing deal for Europe

Medical Developments International Limited (ASX: MVP) is delighted to announce it has agreed to a Term Sheet and will now move to contract with a significant pharmaceutical company having expertise in pain management products to distribute Penthrox® within the 28 member states of the European Union, except for the UK, Ireland, and Hungary where MDI has existing distribution agreements, and within other European countries.

The potential transaction calls for upfront and milestone payments of USD $54.5 million including:

  • USD $7.0 million upon signing; and
  • USD $3.0 million upon receiving Marketing Authorisation approvals in France (expected very shortly) and Belgium (already received); and
  • USD $7.0 million upon receiving reimbursement in Germany, Italy, Spain and France; and
  • the remaining USD$37.5 million relates to sales milestones potentially earnt over the term of the deal.

Additionally MVP will receive a gross margin on product sold to our partner, and royalties based on net sales.

For further information please click on the following link Major Licensing Deal for Europe

Contact Us

for information on our range of products

Find a distributor

in our global network

Investors

invest in a company with
innovative foresight

News

  • Green Whistle gets the Green Light – FDA clears US Penthrox clinical trial

    2 March 2022 ASX ANNOUNCE...

  • MVP FY22 Half Year Results Investor Presentation

    25 February 2022 ASX anno...

  • MVP FY22 Half Year Report and Accounts

    24 February 2022 ASX Anno...

Healthcare Professional Registration

Login to access healthcare professional resources



Remember Me

Forgot password? | Register

Medical Developments International

Address:
4 Caribbean Drive, Scoresby,
Victoria, 3179
Australia
Phone: +61 3 9547 1888
Email: [email protected]
ABN: 14 106 340 667
For Medical Enquiries:

Phone: 1800 PENTHROX (1800 736 847)
Email: [email protected]

Email Newsletter